Intradermal immunisation using the tlr3-ligand poly (i:c) as adjuvant induces mucosal antibody responses and protects against genital hsv-2 infection

HIGHLIGHTS

• who: Emilie Bardel from the (UNIVERSITY) have published the paper: Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection, in the Journal: (JOURNAL)
• what: The authors investigated in mice the potential of ID delivery of sub-unit vaccines in combination with an adjuvant to Npj Vaccines 16010 generate specific Ab responses in the genital and intestinal tracts. The authors show that long-lasting HIV-1 gp140-specific IgG and IgA Ab responses in the vagina can be induced by ID, but not . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.